hydralazine has been researched along with Cardiac Septal Defect in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artman, M | 1 |
| Parrish, MD | 1 |
| Boerth, RC | 1 |
| Boucek, RJ | 1 |
| Graham, TP | 1 |
| Linday, LA | 1 |
| Levin, AR | 1 |
| Klein, AA | 1 |
| Reidenberg, MM | 1 |
| Engle, MA | 1 |
2 other studies available for hydralazine and Cardiac Septal Defect
| Article | Year |
|---|---|
Short-term hemodynamic effects of hydralazine in infants with complete atrioventricular canal defects.
Topics: Blood Circulation; Blood Pressure; Endocardial Cushion Defects; Female; Heart Failure; Heart Rate; H | 1984 |
Acute effects of vasodilators on left-to-right shunts in infants and children.
Topics: Child; Child, Preschool; Female; Heart Rate; Heart Septal Defects; Hemodynamics; Humans; Hydralazine | 1981 |